Clinical Trials · NCT07090343
Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Leiden University Medical Center
- Enrollment
- 826
- Start date
- Apr 2026
- Locations
- See registry
- Primary endpoint
- CV death, non-fatal myocardial infarction, non-fatal stroke, and hospitalization for HF